IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 139 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $6,980,000 | -45.1% | 602,271 | -50.7% | 0.68% | -39.1% |
Q3 2015 | $12,721,000 | +108.0% | 1,220,835 | +140.7% | 1.11% | +155.4% |
Q2 2015 | $6,117,000 | -1.8% | 507,224 | +24.7% | 0.44% | +1.6% |
Q4 2014 | $6,231,000 | +48.0% | 406,711 | +25.1% | 0.43% | +47.1% |
Q3 2014 | $4,210,000 | – | 325,000 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
EMC Capital Management | 43,315 | $417 | 0.31% |